Implications of the HIV testing protocol for refusal bias in seroprevalence surveys

BMC Public Health

Volumn 9, Issue , 2009, Pages

  Reniers, Georges ^a,b,c   Araya, Tekebash ^d   Berhane, Yemane ^d,e   Davey, Gail ^d   Sanders, Eduard J ^f,g  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c PRINCETON UNIVERSITY   (United States)

^d ADDIS ABABA UNIVERSITY   (Ethiopia)

^e ADDIS CONTINENTAL INSTITUTE OF PUBLIC HEALTH   (Ethiopia)

^f KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^g UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DEMOGRAPHY; EDUCATIONAL STATUS; ETHIOPIA; FEMALE; GENDER; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MALE; MARRIAGE; NONRESPONSE BIAS; PATIENT COUNSELING; PREVALENCE; PROSPECTIVE STUDY; SEROPREVALENCE; TREATMENT REFUSAL; VIRUS EXAMINATION; EPIDEMIOLOGY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; PSYCHOLOGICAL ASPECT; REFUSAL TO PARTICIPATE; SERODIAGNOSIS; STATISTICAL MODEL; STATISTICS;

ADOLESCENT; ADULT; AIDS SERODIAGNOSIS; BIAS (EPIDEMIOLOGY); EDUCATIONAL STATUS; ETHIOPIA; FEMALE; HIV INFECTIONS; HUMANS; LIKELIHOOD FUNCTIONS; LOGISTIC MODELS; MALE; MARITAL STATUS; MIDDLE AGED; PATIENT ADMISSION; PREVALENCE; PROSPECTIVE STUDIES; REFUSAL TO PARTICIPATE; YOUNG ADULT;

EID: 67651154612     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-9-163     Document Type: Article

References (35)

1. Measurement of biomarkers in surveys in developing countries: Opportunities and problems. JT Boerma E Holt R Black, Popul Dev Rev 2001 27 2 303 314 10.1111/j.1728-4457.2001.00303.x
2. Reconciling antenatal clinic-based surveillance and population-based survey estimates of HIV prevalence in Sub-Saharan Africa. WHO/UNAIDS, Geneva: WHO/UNAIDS 2003
3. Estimates of HIV-1 prevalence from national population-based surveys as a new gold standard. JT Boerma PD Ghys N Walker, Lancet 2003 362 9399 1929 1931 10.1016/S0140-6736(03)14967-7 14667753 (Pubitemid 37518513)
4. Estimating the global burden of HIV/AIDS: what do we really know about the HIV pandemic? N Walker NC Grassly GP Garnett KA Stanecki PD Ghys, Lancet 2004 363 9427 2180 2185 10.1016/S0140-6736(04)16511-2 15220043 (Pubitemid 38844162)
5. Lessons learned in the conduct, validation, and interpretation of national population based HIV surveys. JM Garcia-Calleja LH Marum CP Carcamo L Kaetano J Muttunga A Way, AIDS 2005 19 Suppl 2 9 17 15930844
6. Population migration and the spread of types 1 and 2 human immunodeficiency viruses. TC Quinn, Proc Natl Acad Sci USA 1994 91 7 2407 2414 8146131 10.1073/pnas.91.7.2407
7. Migration and AIDS. J Decosas F Kane JK Anarfi KD Sodji HU Wagner, Lancet 1995 346 8978 826 828 10.1016/S0140-6736(95)91631-8 7674750
8. The impact of migration on HIV-1 transmission in South Africa: a study of migrant and nonmigrant men and their partners. MN Lurie BG Williams K Zuma D Mkaya-Mwamburi G Garnett AW Sturm MD Sweat J Gittelsohn SS Abdool Karim, Sex Transm Dis 2003 30 2 149 156 10.1097/00007435-200302000-00011 12567174 (Pubitemid 36184364)
9. Non-response bias in estimates of HIV prevalence due to the mobility of absentees in national population-based surveys: a study of nine national surveys. M Marston K Harriss E Slaymaker, Sex Transm Infect 2008 84 Suppl 1 i71 i77 18647870 10.1136/sti.2008.030353
10. Improved data, methods and tools for the 2007 HIV and AIDS estimates and projections. PD Ghys N Walker W McFarland R Miller GP Garnett, Sex Transm Infect 2008 84 Suppl 1 i1 4 18647859 10.1136/sti.2008.032573
11. Comparison of HIV-antibody prevalence in patients consenting to and declining HIV-antibody testing in an STD clinic. HF Hull CJ Bettinger MM Gallaher NM Keller J Wilson GJ Mertz, JAMA 1988 260 7 935 938 10.1001/jama.260.7.935 3398198 (Pubitemid 18191406)
12. Comparison of voluntary and blinded human immunodeficiency virus type 1 (HIV-1) seroprevalence surveys in a high prevalence sexually transmitted disease clinic population. SK Schwarcz GA Bolan TA Kellogg R Kohn GF Lemp, Am J Epidemiol 1993 137 6 600 608 8470661
13. HIV seroprevalence and reasons for refusing and accepting HIV testing. JL Jones P Hutto P Meyer H Dowda WB Gamble Jr RA Gunn, Sex Transm Dis 1993 20 6 334 337 10.1097/00007435-199320060-00006 8108756
14. Characterization of patients accepting and refusing routine, voluntary HIV antibody testing in public sexually transmitted disease clinics. SL Groseclose B Erickson TC Quinn D Glasser CH Campbell EW Hook, Sex Transm Dis 1994 21 1 31 35 10.1097/00007435-199401000-00007 8140486
15. Reasons for HIV antibody test refusal in a heterosexual sexually transmitted disease clinic population. PA Simon M Weber WL Ford F Cheng PR Kerndt, AIDS (London, England) 1996 10 13 1549 1553 8931791
16. Voluntary confidential HIV testing of STD patients in Switzerland, 1990-5: HIV test refusers cause different biases on HIV prevalences in heterosexuals and homo/bisexuals. WJ Paget M Zwahlen AR Eichmann, Genitourin Med 1997 73 6 444 447 9582457
17. Attitudes et comportements des femmes enceintes face au dépistage du HIV Abidjan (Côte D'Ivoire) en 1995 et 1996. Raisons du refus du test et indifference face aux résultats. D Coulibaly P Msellati S Dedy C Welffens-Ekra F Dabis, Sante (Montrouge, France) 1998 8 3 234 238 9690325 (Pubitemid 28351005)
18. Antenatal screening for HIV; are those who refuse testing at higher risk than those who accept testing? EH Boxall N Smith, J Public Health (Oxf) 2004 26 3 285 287 10.1093/pubmed/fdh148 15454598 (Pubitemid 39312933)
19. HIV seropositive in pregnant South African women who initially refuse routine antenatal HIV screening. M Mseleku TH Smith F Guidozzi, BJOG 2005 112 3 370 371 10.1111/j.1471-0528.2004.00424.x 15713157 (Pubitemid 40314018)
20. HIV infection among pregnant women in Bobo-Dioulasso, Burkina Faso: comparison of voluntary and blinded seroprevalence estimates. N Meda MT Zoundi-Guigui P van de Perre M Alary A Ouangre M Cartoux L Mandelbrot P Viens F Dabis, Int J STD AIDS 1999 10 11 738 740 10.1258/0956462991913277 10563562 (Pubitemid 29512000)
21. HIV risk perception and prevalence in a program for prevention of mother-to-child HIV transmission: comparison of women who accept voluntary counseling and testing and those tested anonymously. H Mpairwe L Muhangi PB Namujju A Kisitu A Tumusiime M Muwanga JA Whitworth S Onyango B Biryahwaho AM Elliott, J Acquir Immune Defic Syndr 2005 39 3 354 358 10.1097/01.qai. 0000148081.38331.92 15980698 (Pubitemid 40923218)
22. Using prevalence data from the programme for the prevention of mother-to-child-transmission for HIV-1 surveillance in North Uganda. M Fabiani B Nattabi EO Ayella M Ogwang S Declich, AIDS (London, England) 2005 19 8 823 827 15867497
23. The effect of non-response on population-based HIV prevalence estimates: the case of rural Malawi. F Obare, Social Networks Project Working Papers Philadelphia: University of Pennsylvania 2005 7
24. Evidence from national population-based estimates of bias in HIV prevalence. S Bignami-Van Assche JA Salomon CJL Murray, Population Association of America Annual Meeting. Philadelphia 2005
25. HIV testing in national population-based surveys: experience from the Demographic and Health Surveys. V Mishra M Vaessen JT Boerma F Arnold A Way B Barrere A Cross R Hong J Sangha, Bull World Health Organ 2006 84 7 537 545 16878227 10.2471/BLT.05.029520 (Pubitemid 44186351)
26. Evaluation of bias in HIV seroprevalence estimates from national household surveys. V Mishra B Barrere R Hong S Khan, Sex Transm Infect 2008 84 Suppl 1 i63 i70 18647869 10.1136/sti.2008.030411
27. Response rates for providing a blood specimen for HIV testing an a population-based survey of young adults in Zimbabwe. A McNaghten JM Herold HM Dube ME St Louis, BMC Public Health 2007 7 145 17612395 10.1186/1471-2458-7-145 (Pubitemid 47203120)
28. Population and antenatal-based HIV prevalence estimates in a high contracepting female population in rural South Africa. BD Rice J Batzing-Feigenbaum V Hosegood F Tanser C Hill T Barnighausen K Herbst T Welz ML Newell, BMC Public Health 2007 7 160 17640354 10.1186/1471-2458-7-160 (Pubitemid 47252358)
29. Refusal bias in HIV prevalence estimates from nationally representative seroprevalence surveys. G Reniers J Eaton, AIDS 2009 23 5 621 629 19182677 10.1097/QAD.0b013e3283269e13
30. UNAIDS/WHO, Guidelines for measuring HIV prevalence in population-based surveys Geneva: UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance 2005
31. WHO, ICD-10: International statistical classification of diseases and related health problems Geneva: World Health Organization 1993
32. Sample selection bias as a specification error. JJ Heckman, Econometrica 1979 47 1 153 161 10.2307/1912352
33. Models for sample selection. C Winship RD Mare, Annu Rev of Sociol 1992 18 327 350 10.1146/annurev.so.18.080192.001551
34. Causal inference and the Heckman model. DC Briggs, J Educ Behav Stat 2004 29 4 397 420 10.3102/10769986029004397
35. The influence of antiretroviral therapy on the uptake of HIV testing in Tutume, Botswana. Z Warwick, International Journal of STD & AIDS 2006 17 7 470 481 10.1258/095646206777689189 (Pubitemid 44049676)